SNX7

• Description :

  SNX7 is a Cyclin-Dependent Kinase Inhibitor (CDKI) pathway inhibitor. SNX7 can be used for research of senescence-related and other CDKI-related diseases[1].

• UNSPSC :

  12352005

• Target :

  CDK

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/snx7.html

• Purity :

  99.89

• Solubility :

  DMSO : 250 mg/mL (ultrasonic)

• Smiles :

  CCN1C2=C(C=CC=C2)N=C1/C=C/C3=CC=CO3

• Molecular Formula :

  C15H14N2O

• Molecular Weight :

  238.28

• References & Citations :

  [1]Bey-Dih Chang, et al. Cdki pathway inhibitors and uses thereof. Patent. US20090281129.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, protect from light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [685097-43-2]